This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Beijing Dyne High-Tech Pediatric Pharmaceutical R&d Institute Co., Ltd., Shandong Dyne Marine Biopharmaceutical Co., Ltd. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Longying Shen: Innovator in Pharmaceutical Science
Introduction
Longying Shen is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly through his innovative work on lycorine derivatives. His research focuses on developing pharmaceutical compositions that exhibit antiviral properties.
Latest Patents
Longying Shen holds a patent for a lycorine derivative, which is detailed in his invention titled "Lycorine derivative, and pharmaceutical composition and use thereof." This invention relates to a lycorine derivative of Formula (I), along with a pharmaceutically acceptable salt, a preparation method, and its pharmaceutical composition. The lycorine derivative demonstrates significant antiviral activity, making it useful in treating viral diseases such as hand-foot-mouth disease. He has 1 patent to his name.
Career Highlights
Throughout his career, Longying Shen has worked with various organizations, including Shandong Dyne Marine Biopharmaceutical Co., Ltd and Beijing Dyne High-Tech Pediatric Pharmaceutical R&D Institute Co., Ltd. His work in these companies has contributed to advancements in pediatric pharmaceuticals and biopharmaceuticals.
Collaborations
Longying Shen has collaborated with notable colleagues, including Yajun Yang and Shiqiang Yan. These partnerships have fostered a collaborative environment that enhances research and development in the pharmaceutical sector.
Conclusion
Longying Shen's contributions to pharmaceutical science, particularly through his innovative lycorine derivative, highlight his role as a key inventor in the field. His work continues to impact the treatment of viral diseases, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile